Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder

Podobné jednotky

• Characterizing mortality in patients with AQP4‐Ab + neuromyelitis optica spectrum disorder
  Autor: Francis, A, a další
  Vydáno: (2024)
• The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis
  Autor: Messina, S, a další
  Vydáno: (2021)
• Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
  Autor: Sato, D, a další
  Vydáno: (2014)
• Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
  Autor: Jarius, S, a další
  Vydáno: (2007)
• Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
  Autor: Pittock, S, a další
  Vydáno: (2019)